๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐
@cparkmd
๐Oncologist|๐งฌCancer Researcher|President Ky @ASCO|Advisory Dean/Clinical Professor @UofL Med School |Faculty @ASCO @NCCN |Advisor @MedScape @Onclive @Doximity
ID: 1148627277204340736
http://linkedin.com/in/chandlerparkmd 09-07-2019 16:17:38
9,9K Tweet
21,21K Followers
9,9K Following
Please come to our Session about Novel immunontherapies during IASLC #WCLC24 with Delvys Rodriguez Abreu Charu Aggarwal, MD, MPH, FASCO Ben Creelan, MD Wen-Zhao Zhong Alfredo Addeo MD #lungcancer #lcsm Memorial Cancer Institute Memorial Healthcare System FLASCO @olacancer
Tune in to hear from Drs ๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐ and Stephanie Graff, MD, FACP, FASCO discuss the evolution of treatment for patients with metastatic HR-positive breast cancer, including the role of CDK4/6 inhibitors. Lifespan Health System Norton Healthcare #bcsm onclive.com/view/park-and-โฆ
#WCLC24 is almost here, and Day โ๐ฝ is packed with exciting sessions! Definitely attending the Early-Career Investigator Workshopโwhat other sessions are on the agenda? Aakash Desai, MD, MPH Fawzi Abu Rous, MD Bruna Pellini, MD Misty Dawn Shields Ana I. Velรกzquez Maรฑana, MD, MSc, FASCO Isabel Preeshagul LungCancerRx ๐ซ๐
Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions? Sometimes, but clinical judgement is more important than predefined criteria Andrea Apolo, M.D. Shilpa Gupta joaquim bellmunt Jonathan Rosenberg MD Michiel van der Heijden & Lisa Cordes gbr01.safelinks.protection.outlook.com/?url=https%3A%โฆ
Front row to watch Sumanta K. Pal, MD, FASCO โs terrific internal medicine grand round on gut bacteria and cancer! Neeraj Agarwal, MD, FASCO GU Cancer Research Program @HuntsmanCancer Umang Swami Zeynep Irem Ozay, MD Georges Gebrael University of Utah Department of Internal Medicine Neli Ulrich, PhD Benjamin L Maughan Nicolas Sayegh, MD
Miami docs on their way to IASLC #WCLC24 Edgardo S. Santos, M.D., FACP, FASCO Edgardo S. Santos, M.D., FACP, FASCO Dr. Raja Mudad and many more people in the plane!! hoping for a great conference #lungcancer #lcsm FLASCO OLACANCER
Excited to start a new role on familiar territory at UTSW Simmons Cancer Center Parkland Health in GU oncology and informatics! Special thanks to my mentors and peers at Vanderbilt Hem / Onc DBMI at Vanderbilt University for great learning and support throughout my fellowship/masterโs.
Out in Journal of Clinical Oncology our next piece of the neoadjuvant puzzle in muscle-invasive #bladdercancer. Taxanes could be another good choice of backbone chemo to combine with IO, overcoming the known limits of platinum. #NureCombo provided Nivo/ABX x4 > RC > adj Nivo x13. N=31. 22 pts
Landed in beautiful but somewhat muggy #Seattle starting with passionate #oncopetros Petros Grivas ! Pavlos Msaouel Dr. Bishoy M. Faltas you guys are missing out #MLSSeattle24
โญ๏ธDr. Scott Tykodi Fred Hutchinson Cancer Center gives a masterful discussion on the only adjuvant study that was positive for RCC. He also gives an intriguing discussion of the use of NIVO/IPI for 1st line metastatic RCC with favorable risk . Petros Grivas Rafee Talukder OncoDaily
๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐ Fred Hutchinson Cancer Center Petros Grivas Rafee Talukder OncoDaily Scott is amazing! Itโs an honor for me to work with him at the Fred Hutchinson Cancer Center multidisciplinary kidney cancer clinic! Evan Hall Sarah P. Psutka MD MS Martin Ma
๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐ Fred Hutchinson Cancer Center Petros Grivas Rafee Talukder OncoDaily Evan Hall Sarah P. Psutka MD MS Martin Ma Proud to offer a one stop service to kidney cancer patients as a team Fred Hutchinson Cancer Center !
โญ๏ธLoved this informative talk by Dr. Hiba Khan Fred Hutchinson Cancer Center . Updated table on the PARP inhibitor combination trials . Also a very thoughtful discussion for treatment escalation candidates for non-metastatic prostate cancer. Petros Grivas Evan Hall Martin Ma
